scholarly article | Q13442814 |
P2093 | author name string | Imtiaz A Khan | |
Kenneth H Ely | |||
Lori Casciotti | |||
Martha E Williams | |||
P2860 | cites work | CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells | Q44000881 |
IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells | Q44825785 | ||
Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. | Q46315215 | ||
Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii | Q48464908 | ||
Expression of intracellular IFN-gamma in HSV-1-specific CD8+ T cells identifies distinct responding subpopulations during the primary response to infection. | Q52025483 | ||
IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice. | Q52046728 | ||
TCR alpha beta+ CD4- CD8- T cells differentiate extrathymically in an lck-independent manner and participate in early response against Listeria monocytogenes infection through interferon-gamma production. | Q52193069 | ||
Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. | Q54283162 | ||
CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. | Q54297083 | ||
Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo | Q59054431 | ||
Kinetics and Regulation of NK Activity by Interleukin-2 and Interferon in Acute Toxoplasmosis | Q67703866 | ||
Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice | Q68093960 | ||
CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production | Q72467836 | ||
Antigen-specific CD8+ T cell clone protects against acute Toxoplasma gondii infection in mice | Q72670278 | ||
IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii | Q73050590 | ||
Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii | Q73515059 | ||
Augmentation of the CD8+ T cell response by IFN-gamma in IL-12-deficient mice during Toxoplasma gondii infection | Q77399380 | ||
IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation | Q77658417 | ||
The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens | Q28198712 | ||
IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model | Q33867200 | ||
Serodiagnosis of recently acquired Toxoplasma gondii infection with a recombinant antigen | Q33974763 | ||
Lack of CD4(+) T cells does not affect induction of CD8(+) T-cell immunity against Encephalitozoon cuniculi infection | Q34004978 | ||
Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain | Q34007181 | ||
IL-2 knockout recipient mice reject islet cell allografts | Q34299248 | ||
Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha | Q34529654 | ||
Community study of toxoplasma antibodies in urban and rural schoolchildren aged 4 to 18 years | Q35257302 | ||
Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis | Q35406362 | ||
Interleukin-12 enhances murine survival against acute toxoplasmosis | Q35778829 | ||
Toxoplasmic encephalitis in AIDS. | Q35810946 | ||
Toxoplasmosis in immunoglobulin M-suppressed mice. | Q36336142 | ||
Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice | Q36362549 | ||
A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection | Q36366985 | ||
Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii | Q36367127 | ||
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection | Q36637922 | ||
Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. | Q36641930 | ||
SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections | Q36950623 | ||
Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. | Q37178327 | ||
Constructing polycompetitor cDNAs for quantitative PCR. | Q38315767 | ||
CD8+ T-cell interactions with Toxoplasma gondii: implications for processing of antigen for class-I-restricted recognition. | Q40708644 | ||
Induction and regulation of host cell-mediated immunity by Toxoplasma gondii | Q41047837 | ||
From naive to memory T cells | Q41091863 | ||
Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine | Q41133376 | ||
Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response | Q41603380 | ||
The role of gammadelta T cells in induction of bacterial antigen-specific protective CD8+ cytotoxic T cells in immune response against the intracellular bacteria Listeria monocytogenes | Q43426354 | ||
Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice | Q43806211 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Toxoplasma gondii | Q131003 |
P304 | page(s) | 434-443 | |
P577 | publication date | 2002-02-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cells | |
P478 | volume | 70 |
Q34525371 | A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection |
Q36010732 | A comparative study between excretory/secretory and autoclaved vaccines against RH strain of Toxoplasma gondii in murine models |
Q35102296 | ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18. |
Q33592970 | Absence of both IL-7 and IL-15 severely impairs the development of CD8 T cell response against Toxoplasma gondii |
Q30276224 | Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis. |
Q37521657 | CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis |
Q64074229 | CD8 T Cells Cry for CD4 Help |
Q35038836 | CD8 T Cells and Toxoplasma gondii: A New Paradigm |
Q38461484 | CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection. |
Q37041277 | Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication |
Q36868318 | Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration of dexamathasone |
Q44839512 | DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice |
Q34184744 | DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice |
Q48292361 | DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice |
Q34544141 | Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice |
Q41565237 | Diverse roles for T-bet in the effector responses required for resistance to infection. |
Q46165473 | Downregulated IL-21 Response and T Follicular Helper Cell Exhaustion Correlate with Compromised CD8 T Cell Immunity during Chronic Toxoplasmosis |
Q50893682 | Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models. |
Q45760194 | Evaluation of the adjuvant properties of Astragalus membranaceus and Scutellaria baicalensis GEORGI in the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models |
Q33946644 | Experimental ocular toxoplasmosis in genetically susceptible and resistant mice |
Q34388716 | Foxp4 is dispensable for T cell development, but required for robust recall responses |
Q47840768 | Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection. |
Q56567289 | Immunization With a DNA Vaccine Cocktail Encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 Genes Protects Mice Against Chronic Toxoplasmosis |
Q36575310 | Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis |
Q36646902 | Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles. |
Q33556845 | Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection |
Q41850308 | Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii |
Q34597905 | Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite |
Q37451015 | Long-term immunity to lethal acute or chronic type II Toxoplasma gondii infection is effectively induced in genetically susceptible C57BL/6 mice by immunization with an attenuated type I vaccine strain |
Q30786522 | Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii |
Q27348931 | MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis |
Q37577380 | Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly |
Q33946628 | NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells |
Q35013003 | Neospora caninum-infected cattle develop parasite-specific CD4+ cytotoxic T lymphocytes. |
Q35073845 | Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells |
Q56891292 | PD-L1, TIM-3, and CTLA-4 blockade fail to promote resistance to secondary infection with virulent strains of |
Q35425382 | Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice |
Q35801712 | Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cells |
Q34108177 | Regulation of CD8+ T cell responses to infection with parasitic protozoa |
Q35535516 | Resistance to Toxoplasma gondii infection in mice treated with silk protein by enhanced immune responses |
Q61804925 | Rhoptry antigens as vaccine target |
Q38266459 | Role of Chemokines and Trafficking of Immune Cells in Parasitic Infections |
Q34478935 | Suppression of CD4 T-Cells in the spleen of mice infected with Toxoplasma gondii KI-1 tachyzoites |
Q87410025 | Sustained release of recombinant surface antigen 2 (rSAG2) from poly(lactide-co-glycolide) microparticles extends protective cell-mediated immunity against Toxoplasma gondii in mice |
Q33732215 | The CD8 T-cell road to immunotherapy of toxoplasmosis |
Q37633578 | The importance of toxoplasma gondii infection in diseases presenting with headaches. Headaches and aseptic meningitis may be manifestations of the Jarisch-Herxheimer reaction |
Q35172341 | Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination. |
Q92619978 | Toxoplasma: Immunity and Pathogenesis |
Q37065383 | Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A. |
Search more.